-
-
Call more information
660-596-2224 -
Authors: Jennifer W. He, B.MSc. et al Anesthesiology April 2022, Vol. 136, 577–587. Background Intraabdominal surgeries are frequently performed procedures that lead to a high volume of unplanned readmissions and postoperative complications. Patient sex may be a determinant of adverse outcomes in this population, possibly due to differences in biology or care delivery, but it is […]
Read MoreAuthors: Philip Bickler, M.D., Ph.D. and Kevin K. Tremper, Ph.D., M.D. Anesthesiology May 2022, Vol. 136, 670–671. It is amazing to think that a device developed for aviation research during World War II and implemented into anesthesia care in the mid-1980s is now likely the most common medical device on Earth—with the possible exception of the thermometer. […]
Read MoreAuthor: Richard Novak, MD The Anesthesia Consultant What is a difficult anesthetic? Most people have no real idea what anesthesiologists do. Many imagine an anesthesiologist’s job is to give a patient some “gas” which to keep the patient asleep, while the surgeon (the real doctor) heals the patient. This image is oversimplified and wrong. Anesthesiologists […]
Read MoreAuthors: Nicolas Nesseler, M.D., Ph.D. et et Anesthesiology May 2022, Vol. 136, 732–748. Background Despite expanding use, knowledge on extracorporeal membrane oxygenation support during the COVID-19 pandemic remains limited. The objective was to report characteristics, management, and outcomes of patients receiving extracorporeal membrane oxygenation with a diagnosis of COVID-19 in France and to identify pre-extracorporeal membrane […]
Read MoreAuthor: Richard Novak MD THE ANESTHESIA CONSULTANT In July 2020 the Food and Drug Administration (FDA) approved the intravenous benzodiazepine remimazolam (Byfavo, Acacia Pharma) for use in sedation for procedures of 30 minutes or less. Will anyone utilize this new drug, or is it an expensive addition to our arsenal with few significant advantages over current agents? Remimazolam […]
Read More